Shenzhen Tai Shen (Beijing) Biopharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Tai Shen") received the notice titled "Notice from the Review Center Regarding the Application for Issuing Stocks to Specific Objects by Shenzhen Tai Shen (Beijing) Biopharmaceutical Co., Ltd." (hereinafter referred to as "the Notice") from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") on March 31, 2026.
300204SZSE
Announcement on Receiving the Notice from the Review Center Regarding the Application for Issuing Stocks to Specific Objects by Shenzhen Tai Shen (Beijing) Biopharmaceutical Co., Ltd.
✨ AI Summary
Shenzhen Tai Shen (Beijing) Biopharmaceutical Co., Ltd. received a notice from the Shenzhen Stock Exchange's listing review center on March 31, 2026, regarding its application to issue stocks to specific objects. The review center confirmed that the company meets the issuance and listing conditions. The application will proceed to the China Securities Regulatory Commission for registration, but approval remains uncertain. The company will disclose further information as developments occur.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.